Medline Inc. · NASDAQ:MDLN

Medline — Q1 2026 Earnings Presentation

13 slides from Medline's earnings presentation, May 6, 2026

  1. Slide 1: Medline Q1 2026 Earnings

    Medline Q1 2026 Earnings May 6, 2026

  2. Slide 2: Forward-Looking Statements and Non-GAAP Financial Measures

    Forward-Looking Statements This presentation contains “forward-looking statements” as defined under the U.S. federal securities laws, including, but not limited to, statements, estimates, and projections relating to our business, goals, targets, activities, efforts, initiatives, plans, and programs,

  3. Slide 3: Agenda

    Q1 2026 Financial Results FY 2026 Guidance Agenda 3 © 2026 Medline

  4. Slide 4: Q1 2026 Financial Results

    1 Q1 2026 Financial Results

  5. Slide 5: Q1 2026 highlights

    Q1 2026 highlights • Strong net sales of $7.4 billion, an increase of 10.7% compared to the prior period, and raising full year 2026 Organic Sales1 guidance range to 8.5% to 9.5% • Strong start to the year with total new customer signings2, including competitor displacements and multi-channel wins •

  6. Slide 6: Q1 2026 select financial highlights

    Q1 2026 select financial highlights Net Sales Adjusted EBITDA1 Highlights (versus prior year) • Net sales growth of 10.7%; 180bps +10.7% (10.6)% headwind when adjusting for one less business day in Q1 2026 vs. Q1 2025 • Organic Sales1 growth of 10.1% • Strong net sales growth in Supply $868M Chain S

  7. Slide 7: Q1 2026 net sales by segment and channel

    Q1 2026 net sales by segment and channel Q1 2026 vs. Q1 2025 Segment Channel $0.5B $3.5B $1.7B International Medline Brand U.S. Non-acute +10.0% +6.2% +6.8% $7.4B $7.4B +10.7% +10.7% $3.9B $5.1B Supply Chain U.S. Acute Solutions +12.1% +15.0% Note: Certain amounts and percentages presented in this p

  8. Slide 8: Q1 2026 Medline Brand

    Q1 2026 Medline Brand Highlights Net Sales Segment Adjusted EBITDA1 (versus prior year) +6.2% $3.5B (7.8)% • Surgical Solutions net sales growth of $3.3B $830M $765M 7.4% primarily driven by higher volume +0.7% for operating room and kitting products • Front Line Care net sales growth of 6.0% driven

  9. Slide 9: Q1 2026 Supply Chain Solutions

    Q1 2026 Supply Chain Solutions Highlights Net Sales Segment Adjusted EBITDA1 (versus prior year) $187M $182M • Supply Chain Solutions net sales +2.7% growth of 15.0% primarily driven +15.0% $3.9B by growth in Prime Vendor sales, $3.4B including new customer implementations and existing customer grow

  10. Slide 10: Q1 2026 cash flow and balance sheet highlights

    Q1 2026 cash flow and balance sheet highlights Cash and cash equivalents $2.2 billion as of March 28, 2026 Free Cash Flow1 $316 million Strong free cash flow driven by net income, excluding the impact of non-cash items, partially offset by increased trade receivables due to net sales growth, increas

  11. Slide 11: FY 2026 Guidance

    2 FY 2026 Guidance

  12. Slide 12: FY 2026 guidance

    FY 2026 guidance Prior Current (February 25, 2026) (May 6, 2026) Organic Sales1 Growth 8.0% to 9.0% 8.5% to to 8.5% 9.5% 9.5% Adjusted EBITDA1 $3.5 to $3.6 billion $3.5 to $3.6 billion Net interest expense Net CapEx Tax distributions Estimated GAAP tax rate $575 to $625 million ~$500 million $250 to

  13. Slide 13: Slide 13

Medline — Q1 2026 Earnings Presentation on 6ix